NCT00227214View on ClinicalTrials.gov

Study Evaluating Pneumococcal Meningitis in the Paediatric Population in Spain Four Years After the Marketing of Prevenar.

CompletedOBSERVATIONAL
Enrollment

160

Participants

Timeline

Start Date

January 31, 2004

Primary Completion Date

December 31, 2006

Study Completion Date

December 31, 2006

Conditions
Pneumococcal Meningitis
Trial Locations (39)

Unknown

A Coruña

Alcalá de Henares

Alcorcón

Arrasate / Mondragón

Badalona

Barakaldo

Barcelona

Barco de Valdeorras

Bilbao

Boadilla del Monte

Cee

El Escorial

Esplugues de Llobregat

Estella-Lizarra

Ferrol

Figueres

Getafe

Girona

Granollers

Leganés

Lleida

Lugo

Madrid

Monforte de Lemos

Móstoles

Ourense

Pamplona

Pontevedra

Reus

Ribeira

Sabadell

San Sebastián

Tarragona

Terrassa

Tudela

Verín

Vigo

Vitoria-Gasteiz

Zumarraga

All Listed Sponsors
lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00227214 - Study Evaluating Pneumococcal Meningitis in the Paediatric Population in Spain Four Years After the Marketing of Prevenar. | Biotech Hunter | Biotech Hunter